Abstract
Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA
This evaluation found that among patients who experienced eosinophilia, only one exhibited signs of hypersensitivity, while seven required a change in therapy. This indicates that while eosinophilia is a concern, its direct clinical impact may be limited for the majority of patients. In the cohort experiencing elevated LFTs including AST, ALT, or alkaline phosphatase levels, fewer than 2% necessitated a change in therapy. This low rate suggests that routine LFT monitoring may not always correlate with significant clinical decisions, raising questions about the necessity of frequent lab draws.
Document Type
Poster
Publication Date
12-2025
Recommended Citation
Subart, Stephanie PharmD; Towne, Trent PharmD, BCPS; Pehlke, Sarah PharmD, BCPS; and Beckett, Robert D. PharmD, BCPS, "Evaluation and Optimization of Outpatient Parenteral Antimicrobial Therapy Laboratory Monitoring for Beta-Lactam Antibiotics." (2025). Pharmacy Residency. 32.
https://researchrepository.parkviewhealth.org/pharmresidency/32
